This provider's $20.3M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Medicare payments to this provider grew 167% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $257.25 | $199.11 | 1.29x | $58.14 | $1.2M | 6.1K | 14 |
| 2015 | $241.50 | $185.90 | 1.30x | $55.60 | $1.4M | 7.4K | 16 |
| 2016 | $251.27 | $195.13 | 1.29x | $56.14 | $1.7M | 8.8K | 16 |
| 2017 | $258.45 | $197.73 | 1.31x | $60.72 | $1.8M | 9.2K | 14 |
| 2018 | $243.46 | $186.88 | 1.30x | $56.58 | $2.0M | 10.6K | 13 |
| 2019 | $254.54 | $182.19 | 1.40x | $72.35 | $2.1M | 11.5K | 17 |
| 2020 | $294.46 | $214.83 | 1.37x | $79.63 | $1.9M | 9.0K | 15 |
| 2021 | $290.70 | $220.88 | 1.32x | $69.82 | $2.3M | 10.3K | 14 |
| 2022 | $280.86 | $198.15 | 1.42x | $82.71 | $2.7M | 13.5K | 15 |
| 2023 | $232.75 | $130.31 | 1.79x | $102.44 | $3.2M | 24.8K | 16 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 15.6K | $11.4M | $735.47 | 1.29x |
| J2778 | Injection, ranibizumab, 0.1 mg | 14.8K | $4.0M | $267.82 | 1.33x |
| 92012 | Established patient problem focused exam of visual system | 15.3K | $1.2M | $75.72 | 1.47x |
| 67028 | Injection of drug into eye | 10.4K | $1.1M | $102.02 | 2.10x |
| 92134 | Imaging of retina | 18.5K | $682.2K | $36.92 | 1.52x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 13.4K | $392.3K | $29.19 | 1.30x |
| J3490 | Unclassified drugs | 192 | $309.5K | $1.6K | 3.22x |
| 92226 | Examination of eye by ophthalmoscope with retinal drawing | 9.1K | $297.1K | $32.51 | 1.47x |
| 92014 | Established patient complete exam of visual system | 2.4K | $255.2K | $105.02 | 1.53x |
| 92250 | Photography of the retina | 4.5K | $209.4K | $46.54 | 1.58x |
| 92004 | New patient complete exam of visual system | 1.1K | $138.9K | $127.07 | 1.79x |
| J3590 | Unclassified biologics | 62 | $98.8K | $1.6K | 1.39x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 503 | $61.6K | $122.40 | 1.35x |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 480 | $57.8K | $120.36 | 2.49x |
| 76512 | 2d ultrasound scan of eye tissue and structures | 601 | $43.6K | $72.57 | 1.55x |
| 92225 | Examination of eye by ophthalmoscope with retinal drawing | 977 | $33.9K | $34.74 | 1.34x |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 140 | $28.7K | $204.88 | 1.61x |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 1.2K | $25.0K | $21.53 | 1.62x |
| 92083 | Exam of visual field with extended testing | 388 | $22.5K | $58.02 | 1.45x |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 1.3K | $17.7K | $13.95 | 4.95x |
This provider submits charges 1.41 times higher than what Medicare actually pays.
A markup ratio of 1.41x means for every $100 Medicare pays, this provider initially charges $141. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in NY for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Jonathan Jonisch, MD | Great Neck, NY | $52.3M | ✓ Clear |
| Jeffrey Josef, M.D. | Suffern, NY | $52.2M | ✓ Clear |
| Brett Rosenblatt | Great Neck, NY | $50.0M | ✓ Clear |
| Kenneth Graham | Great Neck, NY | $47.1M | ✓ Clear |
| Glenn Stoller, M.D. | Rockville Centre, NY | $46.4M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data